Delcath Systems (DCTH) Financials

$11.61 +0.27 (+2.38%)

Closing price 05/13/2026 04:00 PM Eastern

Extended Trading

$11.40 -0.21 (-1.77%)

As of 04:16 AM Eastern

Annual Income Statements for Delcath Systems

This table shows Delcath Systems' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-37	-48	-26
Consolidated Net Income / (Loss)	-37	-48	-26
Net Income / (Loss) Continuing Operations	-37	-48	-26
Total Pre-Tax Income	-37	-48	-26
Total Operating Income	-34	-38	-12
Total Gross Profit	2.03	1.43	31
Total Revenue	2.72	2.07	37
Operating Revenue	2.72	2.07	37
Total Cost of Revenue	0.69	0.64	6.19
Operating Cost of Revenue	0.69	0.64	6.19
Total Operating Expenses	36	40	43
Selling, General & Admin Expense	17	22	30
Research & Development Expense	19	18	14
Total Other Income / (Expense), net	-2.69	-9.44	-14
Interest & Investment Income	-2.69	-1.44	0.13
Other Income / (Expense), net	0.00	-8.00	-14
Other Gains / (Losses), net	0.03	-0.06	-0.03
Basic Earnings per Share	($4.12)	($2.94)	($0.93)
Weighted Average Basic Shares Outstanding	8.86M	16.23M	28.51M
Diluted Earnings per Share	($4.12)	($2.94)	($0.93)
Weighted Average Diluted Shares Outstanding	8.86M	16.23M	28.51M
Weighted Average Basic & Diluted Shares Outstanding	10.06M	24.56M	33.40M

This table shows Delcath Systems' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-8.88	-8.47	-9.00	-7.20	-20	-11	-11	-14	1.86	-3.40
Consolidated Net Income / (Loss)	-8.88	-8.47	-9.00	-7.20	-20	-11	-11	-14	1.86	-3.40
Net Income / (Loss) Continuing Operations	-8.88	-8.47	-9.00	-7.20	-20	-11	-11	-14	1.86	-3.40
Total Pre-Tax Income	-8.90	-8.48	-9.01	-7.21	-20	-11	-11	-14	1.83	-3.35
Total Operating Income	-8.17	-7.85	-8.33	-8.00	-11	-11	-10	-3.91	-1.26	3.04
Total Gross Profit	0.67	0.40	0.42	0.35	0.30	0.37	2.24	6.25	9.56	13
Total Revenue	0.91	0.64	0.60	0.50	0.43	0.54	3.14	7.77	11	15
Operating Revenue	0.91	0.64	0.60	0.50	0.43	0.54	3.14	7.77	11	15
Total Cost of Revenue	0.24	0.24	0.18	0.15	0.13	0.17	0.90	1.52	1.64	2.13
Operating Cost of Revenue	0.24	0.24	0.18	0.15	0.13	0.17	0.90	1.52	1.64	2.13
Total Operating Expenses	8.84	8.25	8.74	8.34	11	12	13	10	11	9.94
Selling, General & Admin Expense	4.78	3.82	4.17	4.79	6.20	6.96	8.81	6.77	6.95	7.02
Research & Development Expense	4.07	4.43	4.58	3.56	4.66	4.71	3.70	3.39	3.87	2.91
Total Other Income / (Expense), net	-0.73	-0.63	-0.69	0.79	-9.78	0.24	-0.81	-9.84	3.09	-6.38
Interest & Investment Income	-0.73	-0.65	-0.69	-0.37	-0.40	0.02	-0.20	-0.08	0.11	0.30
Other Income / (Expense), net	0.00	0.02	0.00	1.16	-9.38	0.23	-0.61	-9.76	2.98	-6.68
Other Gains / (Losses), net	0.03	-	0.01	0.01	-0.01	-0.07	-0.02	0.01	0.04	-0.05
Basic Earnings per Share	($0.96)	($0.82)	($0.77)	($0.58)	($1.14)	($0.45)	($0.45)	($0.48)	$0.06	($0.06)
Weighted Average Basic Shares Outstanding	9.22M	8.86M	11.62M	12.46M	17.86M	16.23M	24.89M	28.36M	28.74M	28.51M
Diluted Earnings per Share	($0.96)	($0.82)	($0.77)	($0.58)	($1.14)	($0.45)	($0.45)	($0.48)	$0.06	($0.06)
Weighted Average Diluted Shares Outstanding	9.22M	8.86M	11.62M	12.46M	17.86M	16.23M	24.89M	28.36M	32.35M	28.51M
Weighted Average Basic & Diluted Shares Outstanding	8.60M	10.06M	10.62M	15.28M	22.05M	24.56M	27.79M	28.00M	31.97M	33.40M

This table details how cash moves in and out of Delcath Systems' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-15	0.87	20
Net Cash From Operating Activities	-25	-31	-19
Net Cash From Continuing Operating Activities	-25	-31	-19
Net Income / (Loss) Continuing Operations	-37	-48	-26
Consolidated Net Income / (Loss)	-37	-48	-26
Depreciation Expense	0.13	0.13	0.13
Amortization Expense	0.77	0.90	-0.03
Non-Cash Adjustments To Reconcile Net Income	8.54	16	23
Changes in Operating Assets and Liabilities, net	2.11	-0.91	-16
Net Cash From Investing Activities	-0.21	-20	-0.98
Net Cash From Continuing Investing Activities	-0.21	-20	-0.98
Purchase of Property, Plant & Equipment	-0.21	-0.06	-0.56
Purchase of Investments	0.00	-20	-52
Sale and/or Maturity of Investments	0.00	0.00	52
Net Cash From Financing Activities	10	52	39
Net Cash From Continuing Financing Activities	10	52	39
Repayment of Debt	-0.71	-6.31	-11
Issuance of Common Equity	11	23	7.02
Other Financing Activities, net	0.00	35	43
Other Net Changes in Cash	-0.12	0.06	-0.03
Cash Interest Paid	1.87	1.46	1.24

This table details how cash moves in and out of Delcath Systems' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-0.37	-2.16	12	-9.68	26	-28	-0.89	2.97	-6.47	24
Net Cash From Operating Activities	-5.18	-7.36	-4.26	-9.65	-9.16	-8.18	-9.58	-4.45	-3.64	-1.01
Net Cash From Continuing Operating Activities	-5.18	-7.36	-4.26	-9.65	-9.34	-8.00	-9.58	-4.45	-3.70	-0.94
Net Income / (Loss) Continuing Operations	-8.88	-8.47	-9.00	-7.20	-20	-11	-11	-14	1.86	-3.40
Consolidated Net Income / (Loss)	-8.88	-8.47	-9.00	-7.20	-20	-11	-11	-14	1.86	-3.40
Depreciation Expense	0.07	0.03	0.03	0.03	0.03	0.04	0.03	0.03	0.03	0.04
Amortization Expense	0.53	-0.15	0.19	0.19	0.19	0.31	0.03	0.04	-0.06	-0.04
Non-Cash Adjustments To Reconcile Net Income	1.43	2.41	1.79	0.65	12	1.73	3.61	13	-0.83	7.46
Changes in Operating Assets and Liabilities, net	1.67	-1.18	2.72	-3.32	-1.36	1.05	-2.14	-3.67	-4.71	-5.00
Net Cash From Investing Activities	-0.07	-	0.00	-0.04	0.00	-20	4.66	10	-0.70	-15
Net Cash From Continuing Investing Activities	-0.07	-	0.00	-0.04	0.00	-20	4.66	10	-0.70	-15
Purchase of Property, Plant & Equipment	-0.07	-	0.00	-0.04	0.00	-0.02	-0.01	-0.10	-0.22	-0.23
Purchase of Investments	-	-	0.00	-	-	-20	-10	-10	-11	-21
Sale and/or Maturity of Investments	-	-	0.00	-	-	-	15	21	11	5.69
Net Cash From Financing Activities	4.90	5.25	17	0.01	35	0.00	4.02	-2.85	-2.14	40
Net Cash From Continuing Financing Activities	4.90	5.25	17	0.01	35	0.00	4.02	-2.85	-2.14	40
Repayment of Debt	-	-0.71	-6.31	-	-	-	-3.05	-3.05	-2.50	-2.00
Other Financing Activities, net	-	-	0.00	0.01	35	0.00	0.00	0.43	0.19	42
Other Net Changes in Cash	-0.02	-0.05	0.02	-0.00	0.01	0.03	0.02	-0.01	0.01	-0.05
Cash Interest Paid	0.50	0.54	0.49	0.30	0.34	0.34	0.25	0.13	0.01	0.85

This table presents Delcath Systems' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	18	39	77
Total Current Assets	16	37	74
Cash & Equivalents	7.67	13	32
Restricted Cash	4.15	0.05	0.00
Short-Term Investments	0.00	20	21
Accounts Receivable	0.37	0.24	11
Inventories, net	2.00	3.32	6.93
Prepaid Expenses	1.97	1.09	2.70
Plant, Property, & Equipment, net	1.42	1.35	1.79
Total Noncurrent Assets	0.29	0.10	1.04
Other Noncurrent Operating Assets	0.29	0.10	1.04
Total Liabilities & Shareholders' Equity	18	39	77
Total Liabilities	24	23	7.84
Total Current Liabilities	15	16	6.14
Short-Term Debt	7.85	10	0.00
Accounts Payable	2.02	1.01	0.96
Accrued Expenses	4.69	5.25	5.08
Other Current Liabilities	0.19	0.04	0.11
Total Noncurrent Liabilities	8.99	6.39	1.70
Other Noncurrent Operating Liabilities	1.14	6.39	1.70
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-5.86	16	69
Total Preferred & Common Equity	-5.86	16	69
Preferred Stock	0.00	0.00	0.00
Total Common Equity	-5.86	16	69
Common Stock	452	521	600
Retained Earnings	-457	-505	-532
Accumulated Other Comprehensive Income / (Loss)	-0.08	0.14	0.08

This table presents Delcath Systems' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	20	31	21	48	36	34	32
Total Current Assets	18	29	19	46	34	31	29
Cash & Equivalents	9.83	24	15	40	12	15	8.32
Restricted Cash	4.15	0.05	0.05	0.05	0.05	0.00	0.00
Short-Term Investments	-	-	-	-	15	5.12	5.68
Accounts Receivable	0.54	0.46	0.13	0.21	1.56	3.73	6.94
Inventories, net	1.93	2.34	2.48	2.67	3.63	6.32	6.64
Prepaid Expenses	2.04	1.96	2.28	2.71	1.28	1.45	1.31
Plant, Property, & Equipment, net	1.45	1.39	1.40	1.37	1.34	1.42	1.73
Total Noncurrent Assets	0.29	0.19	0.18	0.11	1.12	1.09	1.07
Other Noncurrent Operating Assets	0.29	0.19	0.18	0.11	1.12	1.09	1.07
Total Liabilities & Shareholders' Equity	20	31	21	48	36	34	32
Total Liabilities	25	25	21	23	21	30	23
Total Current Liabilities	14	13	11	14	13	12	22
Short-Term Debt	6.48	3.77	4.51	7.96	7.36	4.49	2.00
Accounts Payable	2.63	2.43	0.97	0.75	1.49	3.28	0.94
Accrued Expenses	5.14	7.12	5.55	5.23	4.40	4.42	5.71
Other Current Liabilities	0.20	0.09	0.09	0.04	0.10	0.10	13
Total Noncurrent Liabilities	11	12	10	8.88	8.14	17	1.53
Other Noncurrent Operating Liabilities	1.30	6.10	4.93	6.88	8.14	17	1.53
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-5.25	-13	-0.24	25	15	4.19	8.57
Total Preferred & Common Equity	-5.25	-13	-0.24	25	15	4.19	8.57
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-5.25	-13	-0.24	25	15	4.19	8.57
Common Stock	442	453	474	519	531	534	537
Retained Earnings	-447	-466	-474	-494	-516	-530	-528
Accumulated Other Comprehensive Income / (Loss)	-0.06	-0.06	-0.06	-0.06	0.16	0.01	0.01

This table displays calculated financial ratios and metrics derived from Delcath Systems' official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	-23.52%	-24.05%	1,701.69%
EBITDA Growth	-37.34%	-37.03%	41.58%
EBIT Growth	-38.38%	-36.41%	42.66%
NOPAT Growth	-38.00%	-12.79%	67.50%
Net Income Growth	-42.34%	-30.60%	44.66%
EPS Growth	-14.76%	28.64%	68.37%
Operating Cash Flow Growth	-10.38%	-25.25%	40.22%
Free Cash Flow Firm Growth	6.26%	-5.08%	-38.99%
Invested Capital Growth	-415.85%	-230.01%	335.87%
Revenue Q/Q Growth	-35.11%	-4.57%	64.30%
EBITDA Q/Q Growth	-12.02%	-6.54%	21.79%
EBIT Q/Q Growth	-10.43%	-7.54%	21.93%
NOPAT Q/Q Growth	-10.43%	-9.93%	53.61%
Net Income Q/Q Growth	-9.36%	-5.92%	22.68%
EPS Q/Q Growth	-13.81%	11.18%	29.55%
Operating Cash Flow Q/Q Growth	-5.63%	-2.69%	27.74%
Free Cash Flow Firm Q/Q Growth	-3.84%	-3.01%	-45.57%
Invested Capital Q/Q Growth	34.01%	-12.68%	553.46%
Profitability Metrics	-	-	-
Gross Margin	74.77%	69.25%	83.37%
EBITDA Margin	-1,211.95%	-2,186.73%	-70.90%
Operating Margin	-1,245.05%	-1,849.01%	-33.36%
EBIT Margin	-1,245.05%	-2,236.32%	-71.18%
Profit (Net Income) Margin	-1,342.70%	-2,308.86%	-70.92%
Tax Burden Percent	99.92%	100.12%	100.11%
Interest Burden Percent	107.93%	103.12%	99.53%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	-194.43%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	-147.60%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	131.99%
Return on Equity (ROE)	-1,198.36%	-961.44%	-62.44%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-198.39%
Operating Return on Assets (OROA)	-132.79%	-163.54%	-45.97%
Return on Assets (ROA)	-143.21%	-168.85%	-45.81%
Return on Common Equity (ROCE)	-1,198.36%	-961.44%	-62.44%
Return on Equity Simple (ROE_SIMPLE)	623.11%	-302.20%	-38.38%
Net Operating Profit after Tax (NOPAT)	-24	-27	-8.69
NOPAT Margin	-871.54%	-1,294.31%	-23.35%
Net Nonoperating Expense Percent (NNEP)	-343.69%	-226.64%	-46.83%
Return On Investment Capital (ROIC_SIMPLE)	-	-103.09%	-12.64%
Cost of Revenue to Revenue	25.23%	30.75%	16.63%
SG&A Expenses to Revenue	636.37%	1,070.70%	79.43%
R&D to Revenue	683.45%	847.55%	37.29%
Operating Expenses to Revenue	1,319.82%	1,918.26%	116.72%
Earnings before Interest and Taxes (EBIT)	-34	-46	-26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-33	-45	-26
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.00	5.81	5.60
Price to Tangible Book Value (P/TBV)	0.00	5.81	5.60
Price to Revenue (P/Rev)	11.38	44.41	10.35
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	21.38
Enterprise Value to Revenue (EV/Rev)	12.81	33.59	8.92
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	-2.68	0.64	0.00
Long-Term Debt to Equity	-1.34	0.00	0.00
Financial Leverage	-1.22	-1.86	-0.89
Leverage Ratio	8.37	5.69	1.36
Compound Leverage Factor	9.03	5.87	1.36
Debt to Total Capital	159.61%	39.15%	0.00%
Short-Term Debt to Total Capital	79.83%	39.15%	0.00%
Long-Term Debt to Total Capital	79.78%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	-59.61%	60.85%	100.00%
Debt to EBITDA	-0.48	-0.22	0.00
Net Debt to EBITDA	-0.12	0.50	0.00
Long-Term Debt to EBITDA	-0.24	0.00	0.00
Debt to NOPAT	-0.66	-0.38	0.00
Net Debt to NOPAT	-0.16	0.84	0.00
Long-Term Debt to NOPAT	-0.33	0.00	0.00
Altman Z-Score	-41.08	-19.16	20.14
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	1.10	2.26	12.01
Quick Ratio	0.55	1.99	10.44
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-21	-22	-31
Operating Cash Flow to CapEx	-11,937.80%	-53,881.03%	-3,341.86%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.11	0.07	0.65
Accounts Receivable Turnover	13.26	6.80	6.68
Inventory Turnover	0.40	0.24	1.21
Fixed Asset Turnover	1.96	1.49	23.68
Accounts Payable Turnover	0.52	0.42	6.27
Days Sales Outstanding (DSO)	27.52	53.65	54.60
Days Inventory Outstanding (DIO)	907.18	1,528.98	302.45
Days Payable Outstanding (DPO)	706.59	870.83	58.19
Cash Conversion Cycle (CCC)	228.11	711.79	298.86
Capital & Investment Metrics	-	-	-
Invested Capital	-1.99	-6.58	16
Invested Capital Turnover	-3.99	-0.48	8.33
Increase / (Decrease) in Invested Capital	-2.62	-4.58	22
Enterprise Value (EV)	35	69	332
Market Capitalization	31	92	385
Book Value per Share	($0.68)	$0.72	$2.15
Tangible Book Value per Share	($0.68)	$0.72	$2.15
Total Capital	9.83	26	69
Total Debt	16	10	0.00
Total Long-Term Debt	7.84	0.00	0.00
Net Debt	3.87	-22	-53
Capital Expenditures (CapEx)	0.21	0.06	0.56
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-2.56	-1.64	14
Debt-free Net Working Capital (DFNWC)	9.27	31	68
Net Working Capital (NWC)	1.42	21	68
Net Nonoperating Expense (NNE)	13	21	18
Net Nonoperating Obligations (NNO)	3.87	-22	-53
Total Depreciation and Amortization (D&A)	0.90	1.02	0.10
Debt-free, Cash-free Net Working Capital to Revenue	-94.01%	-79.61%	38.66%
Debt-free Net Working Capital to Revenue	340.79%	1,494.43%	181.74%
Net Working Capital to Revenue	52.23%	1,002.91%	181.74%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($4.12)	($2.94)	($0.93)
Adjusted Weighted Average Basic Shares Outstanding	8.86M	16.23M	28.51M
Adjusted Diluted Earnings per Share	($4.12)	($2.94)	($0.93)
Adjusted Weighted Average Diluted Shares Outstanding	8.86M	16.23M	28.51M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	10.06M	24.56M	33.40M
Normalized Net Operating Profit after Tax (NOPAT)	-24	-27	-8.69
Normalized NOPAT Margin	-871.54%	-1,294.31%	-23.35%
Pre Tax Income Margin	-1,343.80%	-2,306.00%	-70.84%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Delcath Systems' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	73.56%	-69.75%	57.94%	-37.89%	-52.10%	-15.52%	425.80%	1,468.89%	2,480.65%	2,701.48%
EBITDA Growth	-15.94%	-79.46%	-0.85%	29.62%	-160.37%	-34.88%	-33.67%	-105.59%	108.58%	66.02%
EBIT Growth	-22.06%	-68.33%	0.36%	27.93%	-143.97%	-41.32%	-30.81%	-99.90%	108.61%	67.14%
NOPAT Growth	-22.06%	-68.65%	0.18%	15.70%	-29.16%	-43.93%	-23.46%	51.08%	82.96%	126.88%
Net Income Growth	-24.59%	-58.44%	0.00%	29.11%	-129.13%	-31.44%	-23.46%	-90.79%	109.16%	69.49%
EPS Growth	-2.13%	-9.33%	30.00%	53.23%	-18.75%	45.12%	41.56%	17.24%	105.26%	86.67%
Operating Cash Flow Growth	-5.56%	-22.06%	33.11%	-59.81%	-76.89%	-11.13%	-124.77%	53.87%	60.27%	87.70%
Free Cash Flow Firm Growth	47.26%	66.46%	137.55%	77.91%	-0.38%	-15.83%	-375.26%	300.05%	19.62%	-499.70%
Invested Capital Growth	-62.89%	-415.85%	-1,774.73%	-330.03%	-93.28%	-230.01%	44.83%	-121.36%	41.39%	335.87%
Revenue Q/Q Growth	13.68%	-29.58%	-6.43%	-17.09%	-12.32%	24.19%	482.37%	147.40%	44.22%	34.82%
EBITDA Q/Q Growth	19.41%	-4.98%	-1.90%	18.36%	-198.13%	45.62%	1.50%	-25.57%	112.44%	-315.37%
EBIT Q/Q Growth	13.84%	4.09%	-6.20%	17.87%	-191.65%	44.44%	1.70%	-25.50%	112.56%	-312.12%
NOPAT Q/Q Growth	13.84%	3.90%	-6.00%	3.94%	-32.00%	-7.09%	9.08%	61.94%	54.02%	268.97%
Net Income Q/Q Growth	12.62%	4.56%	-6.23%	19.98%	-182.42%	45.25%	0.22%	-23.67%	113.57%	-282.30%
EPS Q/Q Growth	22.58%	14.58%	6.10%	24.68%	-96.55%	60.53%	0.00%	-6.67%	112.50%	-200.00%
Operating Cash Flow Q/Q Growth	14.21%	-42.09%	42.06%	-126.27%	5.05%	10.73%	-17.19%	53.56%	18.22%	72.36%
Free Cash Flow Firm Q/Q Growth	41.05%	36.91%	244.29%	-141.16%	-167.87%	27.19%	-242.87%	129.92%	-207.63%	-443.20%
Invested Capital Q/Q Growth	-156.15%	34.01%	-372.25%	46.13%	-15.13%	-12.68%	21.04%	-116.12%	69.52%	553.46%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	74.06%	62.70%	69.68%	69.70%	69.35%	68.27%	71.23%	80.44%	85.36%	85.92%
EBITDA Margin	-835.87%	-1,246.08%	-1,356.95%	-1,336.16%	-4,543.32%	-1,989.42%	-344.98%	-175.10%	15.11%	-24.13%
Operating Margin	-902.10%	-1,231.03%	-1,394.47%	-1,615.56%	-2,432.26%	-2,097.22%	-327.43%	-50.37%	-11.24%	20.13%
EBIT Margin	-902.10%	-1,228.68%	-1,394.47%	-1,381.21%	-4,594.47%	-2,055.29%	-346.93%	-175.99%	15.32%	-24.11%
Profit (Net Income) Margin	-979.80%	-1,327.90%	-1,507.54%	-1,454.95%	-4,686.64%	-2,066.05%	-353.97%	-176.94%	16.64%	-22.50%
Tax Burden Percent	99.71%	99.86%	99.86%	99.92%	100.02%	100.66%	100.20%	99.93%	101.91%	101.58%
Interest Burden Percent	108.93%	108.23%	108.26%	105.43%	101.98%	99.86%	101.83%	100.61%	106.59%	91.90%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	117.31%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	131.93%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-117.98%
Return on Equity (ROE)	-1,030.34%	-1,198.36%	-694.27%	2,172.99%	-462.32%	-961.44%	-500.09%	-2,852.05%	-205.01%	-0.67%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-198.39%
Operating Return on Assets (OROA)	-138.32%	-131.05%	-141.48%	-172.90%	-293.27%	-150.30%	-47.93%	-76.06%	8.75%	-15.57%
Return on Assets (ROA)	-150.24%	-141.63%	-152.95%	-182.13%	-299.16%	-151.09%	-48.90%	-76.48%	9.51%	-14.54%
Return on Common Equity (ROCE)	-1,030.34%	-1,198.36%	518.27%	2,172.99%	-462.32%	-961.44%	-38.78%	-2,852.05%	-205.01%	-0.67%
Return on Equity Simple (ROE_SIMPLE)	636.35%	0.00%	279.20%	0.00%	-182.10%	0.00%	-340.55%	-1,343.70%	-398.13%	0.00%
Net Operating Profit after Tax (NOPAT)	-5.72	-5.50	-5.83	-5.60	-7.39	-7.91	-7.19	-2.74	-1.26	2.13
NOPAT Margin	-631.47%	-861.72%	-976.13%	-1,130.89%	-1,702.58%	-1,468.05%	-229.20%	-35.26%	-11.24%	14.09%
Net Nonoperating Expense Percent (NNEP)	-55.59%	-79.79%	-32.76%	-101.49%	-91.43%	-34.87%	-22.69%	-108.71%	14.68%	-14.62%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-30.52%	-	-	-	3.09%
Cost of Revenue to Revenue	25.94%	37.30%	30.32%	30.30%	30.65%	31.73%	28.77%	19.56%	14.64%	14.08%
SG&A Expenses to Revenue	527.48%	599.22%	697.65%	967.07%	1,427.42%	1,291.84%	280.79%	87.11%	62.08%	46.50%
R&D to Revenue	448.68%	694.51%	766.50%	718.18%	1,074.19%	873.65%	117.87%	43.70%	34.52%	19.30%
Operating Expenses to Revenue	976.16%	1,293.73%	1,464.15%	1,685.25%	2,501.61%	2,165.49%	398.66%	130.81%	96.60%	65.79%
Earnings before Interest and Taxes (EBIT)	-8.17	-7.84	-8.33	-6.84	-20	-11	-11	-14	1.72	-3.64
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-7.57	-7.95	-8.10	-6.61	-20	-11	-11	-14	1.69	-3.64
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	2.50	5.81	8.01	55.48	29.50	5.60
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	2.50	5.81	8.01	55.48	29.50	5.60
Price to Revenue (P/Rev)	6.57	11.38	19.69	23.49	28.59	44.41	25.43	19.58	11.17	10.35
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	21.38
Enterprise Value to Revenue (EV/Rev)	7.10	12.81	20.94	21.66	14.47	33.59	21.13	18.28	10.64	8.92
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-3.09	-2.68	1.81	-40.34	0.40	0.64	0.50	1.07	0.23	0.00
Long-Term Debt to Equity	-1.85	-1.34	1.10	-21.70	0.08	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-1.75	-1.22	-1.84	1.02	-1.45	-1.86	-1.73	-5.12	-1.28	-0.89
Leverage Ratio	8.43	8.37	5.51	-13.64	3.48	5.69	3.35	13.91	2.38	1.36
Compound Leverage Factor	9.19	9.06	5.96	-14.38	3.55	5.69	3.41	14.00	2.54	1.25
Debt to Total Capital	147.86%	159.61%	64.39%	102.54%	28.71%	39.15%	33.48%	51.72%	18.92%	0.00%
Short-Term Debt to Total Capital	59.12%	79.83%	25.37%	47.37%	22.94%	39.15%	33.48%	51.72%	18.92%	0.00%
Long-Term Debt to Total Capital	88.73%	79.78%	39.02%	55.17%	5.77%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	123.61%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-47.86%	-59.61%	-87.99%	-2.54%	71.29%	60.85%	66.52%	48.28%	81.08%	100.00%
Debt to EBITDA	-0.55	-0.48	-0.29	-0.32	-0.23	-0.22	-0.15	-0.08	-0.06	0.00
Net Debt to EBITDA	-0.08	-0.12	0.45	0.16	0.72	0.50	0.41	0.28	0.36	0.00
Long-Term Debt to EBITDA	-0.33	-0.24	-0.18	-0.17	-0.05	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	-0.76	-0.66	-0.40	-0.43	-0.41	-0.38	-0.26	-0.18	-0.11	0.00
Net Debt to NOPAT	-0.10	-0.16	0.62	0.21	1.26	0.84	0.71	0.61	0.64	0.00
Long-Term Debt to NOPAT	-0.45	-0.33	-0.24	-0.23	-0.08	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	-31.20	-36.27	-20.16	-30.23	-13.44	-16.16	-16.94	-17.49	-15.61	21.12
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	174.65%	0.00%	0.00%	0.00%	92.25%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.28	1.10	2.16	1.75	3.30	2.26	2.52	2.55	1.34	12.01
Quick Ratio	0.72	0.55	1.84	1.32	2.91	1.99	2.15	1.92	0.97	10.44
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-4.56	-2.87	4.15	-1.71	-4.57	-3.33	-11	3.41	-3.68	-20
Operating Cash Flow to CapEx	-7,616.18%	0.00%	0.00%	-24,120.00%	0.00%	-43,042.11%	-73,723.08%	-4,406.93%	-1,685.19%	-439.30%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.15	0.11	0.10	0.13	0.06	0.07	0.14	0.43	0.57	0.65
Accounts Receivable Turnover	13.83	13.26	9.24	9.33	5.83	6.80	4.56	6.17	6.34	6.68
Inventory Turnover	0.37	0.40	0.38	0.36	0.31	0.24	0.45	0.62	0.91	1.21
Fixed Asset Turnover	2.96	1.96	2.10	1.84	1.53	1.49	3.38	8.41	14.59	23.68
Accounts Payable Turnover	0.30	0.52	0.45	0.53	0.41	0.42	0.69	1.28	5.01	6.27
Days Sales Outstanding (DSO)	26.40	27.52	39.51	39.12	62.58	53.65	80.10	59.20	57.55	54.60
Days Inventory Outstanding (DIO)	999.01	907.18	951.45	1,026.00	1,194.05	1,528.98	803.03	588.87	401.34	302.45
Days Payable Outstanding (DPO)	1,205.83	706.59	803.31	688.46	880.00	870.83	526.52	284.19	72.86	58.19
Cash Conversion Cycle (CCC)	-180.42	228.11	187.65	376.65	376.62	711.79	356.61	363.88	386.04	298.86
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-3.02	-1.99	-9.41	-5.07	-5.84	-6.58	-5.19	-11	-3.42	16
Invested Capital Turnover	-1.72	-3.99	-0.66	-0.84	-0.49	-0.48	-0.63	-1.46	-4.89	8.33
Increase / (Decrease) in Invested Capital	-1.17	-2.62	-9.97	-3.89	-2.82	-4.58	4.22	-6.15	2.42	22
Enterprise Value (EV)	30	35	62	57	31	69	97	217	241	332
Market Capitalization	28	31	58	62	62	92	117	233	253	385
Book Value per Share	($0.61)	($0.68)	($1.30)	($0.02)	$1.62	$0.72	$0.60	$0.15	$0.31	$2.15
Tangible Book Value per Share	($0.61)	($0.68)	($1.30)	($0.02)	$1.62	$0.72	$0.60	$0.15	$0.31	$2.15
Total Capital	11	9.83	15	9.52	35	26	22	8.68	11	69
Total Debt	16	16	9.57	9.76	9.96	10	7.36	4.49	2.00	0.00
Total Long-Term Debt	9.73	7.84	5.80	5.25	2.00	0.00	0.00	0.00	0.00	0.00
Net Debt	2.23	3.87	-15	-4.83	-31	-22	-20	-15	-12	-53
Capital Expenditures (CapEx)	0.07	0.00	0.00	0.04	-0.00	0.02	0.01	0.10	0.22	0.23
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-3.47	-2.56	-4.89	-1.72	-0.43	-1.64	0.49	3.69	-4.69	14
Debt-free Net Working Capital (DFNWC)	11	9.27	19	13	40	31	28	24	9.30	68
Net Working Capital (NWC)	4.03	1.42	16	8.36	32	21	20	19	7.30	68
Net Nonoperating Expense (NNE)	3.16	2.97	3.17	1.60	13	3.22	3.92	11	-3.12	5.53
Net Nonoperating Obligations (NNO)	2.23	3.87	-15	-4.83	-31	-22	-20	-15	-12	-53
Total Depreciation and Amortization (D&A)	0.60	-0.11	0.22	0.22	0.22	0.36	0.06	0.07	-0.02	-0.00
Debt-free, Cash-free Net Working Capital to Revenue	-82.74%	-94.01%	-166.47%	-65.33%	-20.06%	-79.61%	10.68%	31.09%	-20.73%	38.66%
Debt-free Net Working Capital to Revenue	250.95%	340.79%	659.67%	488.16%	1,852.03%	1,494.43%	600.43%	198.68%	41.06%	181.74%
Net Working Capital to Revenue	96.28%	52.23%	531.35%	317.07%	1,484.38%	1,002.91%	440.74%	160.87%	32.23%	181.74%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.92)	($0.82)	($0.77)	($0.58)	($1.14)	($0.45)	($0.45)	($0.48)	$0.06	($0.06)
Adjusted Weighted Average Basic Shares Outstanding	9.22M	8.86M	11.62M	12.46M	17.86M	16.23M	24.89M	28.36M	28.74M	28.51M
Adjusted Diluted Earnings per Share	($0.92)	($0.82)	($0.77)	($0.58)	($1.14)	($0.45)	($0.45)	($0.48)	$0.06	($0.06)
Adjusted Weighted Average Diluted Shares Outstanding	9.22M	8.86M	11.62M	12.46M	17.86M	16.23M	24.89M	28.36M	32.35M	28.51M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	8.60M	10.06M	10.62M	15.28M	22.05M	24.56M	27.79M	28.00M	31.97M	33.40M
Normalized Net Operating Profit after Tax (NOPAT)	-5.72	-5.50	-5.83	-5.60	-7.39	-7.91	-7.19	-2.74	-0.88	2.13
Normalized NOPAT Margin	-631.47%	-861.72%	-976.13%	-1,130.89%	-1,702.58%	-1,468.05%	-229.20%	-35.26%	-7.87%	14.09%
Pre Tax Income Margin	-982.67%	-1,329.78%	-1,509.72%	-1,456.16%	-4,685.48%	-2,052.50%	-353.27%	-177.07%	16.33%	-22.15%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Below are the top trends from Delcath Systems (DCTH) quarterly statements over the last four years, focused on the main drivers retail investors care about.

Q4 2024 revenue rose to $15.1 million with gross profit of $12.974 million, delivering a gross margin of about 86% (gross profit margin roughly 86%).
Q4 2024 showed positive quarterly operating income of $3.039 million, indicating improved profitability from core operations.
Q3 2024 net income was $1.864 million (EPS $0.06), marking a rare positive quarterly bottom line in the period.
2024 financing actions boosted liquidity, with net cash from continuing financing activities around $40.4 million in both Q3 and Q4 2024 (largely from equity financing), supporting a higher cash runway.
Gross margins improved across 2024, rising from about 71% in Q1 2024 to roughly 86% by Q4 2024 as cost of revenue remained controlled.
Operating cash flow has generally been negative across most quarters, though it improved by Q4 2024 (net cash from continuing operating activities around -$0.94 million).
The company has relied on equity financing to fund operations, reflected by sizable financing inflows in 2024, which could lead to share dilution.
Profitability has been volatile across quarters in 2022–2024, with several quarters posting losses despite some periods of quarterly profit (e.g., Q3 2024).
Net income has been negative in most quarters, including -$13.741 million in Q2 2024 and -$11.111 million in Q1 2024, indicating ongoing earnings headwinds.
Cumulative negative retained earnings remained large (approximately -$530 million by Q3 2024), signaling a substantial cumulative deficit despite recent quarterly improvements.

05/14/26 05:21 AM ETAI Generated. May Contain Errors.

Delcath Systems Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Delcath Systems' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

Delcath Systems' net income appears to be on a downward trend, with a most recent value of -$26.39 million in 2024, falling from -$36.51 million in 2022. The previous period was -$47.68 million in 2023. View Delcath Systems' forecast to see where analysts expect Delcath Systems to go next.

Delcath Systems' total operating income in 2024 was -$12.41 million, based on the following breakdown:

Total Gross Profit: $31.02 million
Total Operating Expenses: $43.43 million

Over the last 2 years, Delcath Systems' total revenue changed from $2.72 million in 2022 to $37.21 million in 2024, a change of 1,268.3%.

Delcath Systems' total liabilities were at $7.84 million at the end of 2024, a 65.7% decrease from 2023, and a 66.9% decrease since 2022.

In the past 2 years, Delcath Systems' cash and equivalents has ranged from $7.67 million in 2022 to $32.41 million in 2024, and is currently $32.41 million as of their latest financial filing in 2024.

Over the last 2 years, Delcath Systems' book value per share changed from -0.68 in 2022 to 2.15 in 2024, a change of -415.5%.

Related Companies

Financial statements for NASDAQ:DCTH last updated on 4/6/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Delcath Systems (DCTH) Financials

Financials Breakdown Chart

Key Financial Trends

Delcath Systems Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Delcath Systems (DCTH) Financials

Annual Income Statements for Delcath Systems

Quarterly Income Statements for Delcath Systems

Annual Cash Flow Statements for Delcath Systems

Quarterly Cash Flow Statements for Delcath Systems

Annual Balance Sheets for Delcath Systems

Quarterly Balance Sheets for Delcath Systems

Annual Metrics And Ratios for Delcath Systems

Quarterly Metrics And Ratios for Delcath Systems

Financials Breakdown Chart

Key Financial Trends

Delcath Systems Financials - Frequently Asked Questions

When does Delcath Systems' fiscal year end?

How has Delcath Systems' net income changed over the last 2 years?

What is Delcath Systems' operating income?

How has Delcath Systems' revenue changed over the last 2 years?

How much debt does Delcath Systems have?

How much cash does Delcath Systems have?

How has Delcath Systems' book value per share changed over the last 2 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools